Mira Pharmaceuticals, Common Stock Price on November 22, 2024
| MIRA Stock | 1.43 0.14 10.85% |
If you're considering investing in MIRA Stock, it is important to understand the factors that can impact its price. As of today, the current price of MIRA Pharmaceuticals, stands at 1.43, as last reported on the 2nd of December, with the highest price reaching 1.44 and the lowest price hitting 1.27 during the day. MIRA Pharmaceuticals, has Sharpe Ratio of -0.0402, which conveys that the firm had a -0.0402% return per unit of volatility over the last 3 months. MIRA Pharmaceuticals, exposes twenty-two different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please verify MIRA Pharmaceuticals,'s mean deviation of 4.9, and Risk Adjusted Performance of (0.01) to check out the risk estimate we provide.
At present, MIRA Pharmaceuticals,'s Total Stockholder Equity is projected to increase significantly based on the last few years of reporting. The current year's Other Stockholder Equity is expected to grow to about 26.9 M, whereas Common Stock Shares Outstanding is forecasted to decline to about 17.3 M. . At present, MIRA Pharmaceuticals,'s Price Book Value Ratio is projected to increase significantly based on the last few years of reporting. The current year's Price To Book Ratio is expected to grow to 4.68, whereas Price Earnings Ratio is forecasted to decline to (1.71). MIRA Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
MIRA |
Sharpe Ratio = -0.0402
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | MIRA |
Estimated Market Risk
| 7.08 actual daily | 63 63% of assets are less volatile |
Expected Return
| -0.28 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.04 actual daily | 0 Most of other assets perform better |
Based on monthly moving average MIRA Pharmaceuticals, is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of MIRA Pharmaceuticals, by adding MIRA Pharmaceuticals, to a well-diversified portfolio.
Price Book 5.9779 | Book Value 0.296 | Enterprise Value 17.8 M | Enterprise Value Ebitda (1.45) | Shares Float 10 M |
Related Headline
QCR Holdings Headline on 22nd of November 2024
QCR Holdings, Inc. Announces a Cash Dividend of 0.06 Per Sha... by finance.yahoo.com
MOLINE, Ill., Nov. 22, 2024 -- QCR Holdings, Inc. today announced that on November 20, 2024, the Companys Board of Directors declared a cash dividend of 0.06 per share payable on January 3, 2025, to holders of common stock of the Company of record on December 13, 2024. About UsQCR Holdings, Inc., headquartered in Moline, Illinois, is a relationship-driven, multi-bank holding company serving the Quad Cities, Cedar Rapids, Cedar Valley, Des Moines
MIRA Pharmaceuticals, Valuation on November 22, 2024
It is possible to determine the worth of MIRA Pharmaceuticals, on a given historical date. On November 22, 2024 MIRA was worth 1.28 at the beginning of the trading date compared to the closed value of 1.32. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of MIRA Pharmaceuticals, stock. Still, in general, we apply an absolute valuation method to find MIRA Pharmaceuticals,'s value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of MIRA Pharmaceuticals, where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against MIRA Pharmaceuticals,'s related companies.
| Open | High | Low | Close | Volume | |
| 1.26 | 1.33 | 1.19 | 1.26 | 458,429 | |
11/22/2024 | 1.28 | 1.34 | 1.23 | 1.32 | 372,738 |
| 1.35 | 1.43 | 1.27 | 1.31 | 571,158 |
| Backtest MIRA Pharmaceuticals, | | | MIRA Pharmaceuticals, History | | | MIRA Pharmaceuticals, Valuation | Previous | Next |
MIRA Pharmaceuticals, Trading Date Momentum on November 22, 2024
| On November 25 2024 MIRA Pharmaceuticals, Common was traded for 1.31 at the closing time. The top price for the day was 1.43 and the lowest listed price was 1.27 . The trading volume for the day was 571.2 K. The trading history from November 25, 2024 was a factor to the next trading day price decrease. The trading delta at closing time against the next closing price was 0.76% . The trading delta at closing time against the current closing price is 3.79% . |
MIRA Pharmaceuticals, Fundamentals Correlations and Trends
By evaluating MIRA Pharmaceuticals,'s financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among MIRA Pharmaceuticals,'s main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. MIRA financial account trend analysis is a perfect complement when working with valuation or volatility modules.About MIRA Pharmaceuticals, Stock history
MIRA Pharmaceuticals, investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for MIRA is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in MIRA Pharmaceuticals, will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing MIRA Pharmaceuticals, stock prices may prove useful in developing a viable investing in MIRA Pharmaceuticals,
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 18.6 M | 17.3 M | |
| Net Loss | -6.4 M | -6 M |
MIRA Pharmaceuticals, Stock Technical Analysis
MIRA Pharmaceuticals, technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
MIRA Pharmaceuticals, Period Price Range
Low | December 2, 2024
| High |
0.00 | 0.00 |
MIRA Pharmaceuticals, Common cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
MIRA Pharmaceuticals, December 2, 2024 Market Strength
Market strength indicators help investors to evaluate how MIRA Pharmaceuticals, stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading MIRA Pharmaceuticals, shares will generate the highest return on investment. By undertsting and applying MIRA Pharmaceuticals, stock market strength indicators, traders can identify MIRA Pharmaceuticals, Common entry and exit signals to maximize returns
MIRA Pharmaceuticals, Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for MIRA Pharmaceuticals,'s price direction in advance. Along with the technical and fundamental analysis of MIRA Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of MIRA to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0.01) | |||
| Jensen Alpha | (0.20) | |||
| Total Risk Alpha | (1.40) | |||
| Treynor Ratio | 2.47 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Complementary Tools for MIRA Stock analysis
When running MIRA Pharmaceuticals,'s price analysis, check to measure MIRA Pharmaceuticals,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy MIRA Pharmaceuticals, is operating at the current time. Most of MIRA Pharmaceuticals,'s value examination focuses on studying past and present price action to predict the probability of MIRA Pharmaceuticals,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move MIRA Pharmaceuticals,'s price. Additionally, you may evaluate how the addition of MIRA Pharmaceuticals, to your portfolios can decrease your overall portfolio volatility.
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio |